The present work is addressing the latest advances made in understanding the molecular mechanisms of vascular aging. Increased production of reactive oxygen species (ROS) is the common denominator of vascular aging, endothelial dysfunction and atherosclerosis. ROS are generated by different intracellular molecular pathways. In view of its role in determining the redox state of the cells and their responses to free radicals, mitochondrial p66Shc protein has been regarded as part of a putative transduction pathway relevant to endothelial integrity. Future efforts should translate our knowledge of the mechanisms of aging and its interaction with risk factors into the development of new therapeutic strategies to prevent age-associated cardiovascular disease.

p66 Shc as the engine of vascular aging / Paneni, Francesco; Cosentino, Francesco. - In: CURRENT VASCULAR PHARMACOLOGY. - ISSN 1570-1611. - 10:6(2012), pp. 697-699. [10.2174/157016112803520747]

p66 Shc as the engine of vascular aging.

PANENI, FRANCESCO;COSENTINO, Francesco
2012

Abstract

The present work is addressing the latest advances made in understanding the molecular mechanisms of vascular aging. Increased production of reactive oxygen species (ROS) is the common denominator of vascular aging, endothelial dysfunction and atherosclerosis. ROS are generated by different intracellular molecular pathways. In view of its role in determining the redox state of the cells and their responses to free radicals, mitochondrial p66Shc protein has been regarded as part of a putative transduction pathway relevant to endothelial integrity. Future efforts should translate our knowledge of the mechanisms of aging and its interaction with risk factors into the development of new therapeutic strategies to prevent age-associated cardiovascular disease.
2012
p66shc; endothelial dysfunction; p66(shc); oxidative stress; aging
01 Pubblicazione su rivista::01a Articolo in rivista
p66 Shc as the engine of vascular aging / Paneni, Francesco; Cosentino, Francesco. - In: CURRENT VASCULAR PHARMACOLOGY. - ISSN 1570-1611. - 10:6(2012), pp. 697-699. [10.2174/157016112803520747]
File allegati a questo prodotto
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/516537
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? 5
  • Scopus 17
  • ???jsp.display-item.citation.isi??? 16
social impact